More on this research

3 Data Trends to Consider Now as you Develop your Decentralized Clinical Trial (DCT) Strategy
3 Data Trends to Consider Now as you Develop your Decentralized Clinical Trial (DCT) Strategy
Powering DCT with Next-Gen eClinical Data Accelerates Clinical Trial Transformation

Learn more about Medable's impact in 2021 and the progress we made toward our mission.

Click to play our company 2021 overview.

Join Medable, EY, BMS, Syenos, Astellas and more at the Digital Medicine & Medtech Showcase
Virtually 1/10-1/19

Need a crash course on the current and future states of clinical research?

Take some to learn what the future holds for pharma and digital technology, re-think how clinical trials are run with DCT, and understand if pharma is ready to turn the page on inclusivity at JPM.

Scroll below to read through our sessions and register, or fill out the form to the right to book a 15-minute meeting with a Medable DCT expert ahead of the show.

Let's Connect

Program Insights

The 2022 program will put a spotlight on how COVID-19 accelerated the adoption of all things digital and provide insights from industry investors, deal makers, and company executives on the future of this space.

Watch our sessions below

Watch now:
Inclusivity in medicine: change accelerators/change makers
Speakers: Sans Thakur: Chief Growth Officer, Medable Inc. (Facilitator), Yele Aluko: Chief Medical Officer, Ernst & Young, Daniel Perez: Chief Executive Officer, Macro Trial
Watch now:
Decentralized Clinical Trials
Speakers: Medable - Alison Holland, Executive General Manager, Digital and Decentralized Solutions, Juliet Mortiz, COO Illingworth 
Day 3 - January 12
Pharma’s Digital Future
Speakers: Matt Miller - CEO, StudyKIK, Chihiro Hosoya - Head of Venture Management and Business Development, Astellas Rx+ Business Accelerator, Michelle Longmire - CEO and Co-Founder, Medable, Owen McCarthy - President and Founder, MedRhythms